Analysed ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) News Sources
Actinogen Medical advances pivotal XanaMIA trial towards November readout - ICYMI
01-08-2026
proactiveinvestors.com
Actinogen Medical targets Alzheimer’s treatment gap in projected $20BN market
05-08-2026
proactiveinvestors.com
Actinogen Medical outlines scientific case for Xanamem in Alzheimer’s disease ahead of pivotal trial results
05-08-2026
proactiveinvestors.com
The Small Cap Watch: Healthcare, critical minerals and gold explorers advance projects
05-08-2026
proactiveinvestors.com
Small Cap Watch: Actinogen hosts Alzheimer’s forum; SEG unveils MediaWorks deal and Pro Medicus wins US contract
11-08-2026
proactiveinvestors.com
Actinogen Medical to discuss future of Alzheimer’s treatment as pivotal XanaMIA readout approaches
11-08-2026
proactiveinvestors.com
Actinogen Medical eyes pivotal November Alzheimer’s trial results after key FY2026 milestones
27-08-2026
proactiveinvestors.com
Actinogen Medical secures $4.77 million option underwriting ahead of pivotal Alzheimer’s trial results
01-09-2026
proactiveinvestors.com
Actinogen Medical completes final XanaMIA patient visit; November Alzheimer’s trial results on track
22-09-2026
proactiveinvestors.com
What is the current price of ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS)?
The current price of ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) is $0.06.
ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) since the previous trading day is $0.025.
ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) since the previous trading day is 71.4286%.
What is the most recent average sentiment score for ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS)?
The most recent average sentiment score for ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) is 80 out of 100.
What is the most recent average sentiment for ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS)?
The most recent sentiment for ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS) is .
SEC-8K** Filing Available For ACTINOGEN MEDICAL LTD (ATGGF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.